MiMedx Group
(NASDAQ:MDXG)
$3.17
0.05[1.60%]
Last update: 12:30PM (Delayed 15-Minutes)
Get Real Time Here
Day Range3.06 - 3.1852 Wk Range2.59 - 6.35Open / Close3.08 / -Float / Outstanding112.2M / 113.7M
Vol / Avg.96.3K / 517.8KMkt Cap360.3MP/E-50d Avg. Price2.99
Div / Yield-Payout Ratio-Total Float112.2MEPS-0.09

MiMedx Group Stock (NASDAQ:MDXG), Quotes and News Summary

MiMedx Group Stock (NASDAQ: MDXG) stock price, news, charts, stock research, profile.

Loading...
Day Range3.06 - 3.1852 Wk Range2.59 - 6.35Open / Close3.08 / -Float / Outstanding112.2M / 113.7M
Vol / Avg.96.3K / 517.8KMkt Cap360.3MP/E-50d Avg. Price2.99
Div / Yield-Payout Ratio-Total Float112.2MEPS-0.09
Zacks Small Cap Research - Aug 4, 2022, 9:43AM
Zacks Small Cap Research - May 5, 2022, 12:51PM
Zacks Small Cap Research - Mar 1, 2022, 11:47AM
Zacks Small Cap Research - Jan 20, 2022, 1:24PM
Zacks Small Cap Research - Jan 12, 2022, 10:20AM
Zacks Small Cap Research - Dec 16, 2021, 10:15AM
Zacks Small Cap Research - Nov 5, 2021, 9:49AM
Zacks Small Cap Research - Sep 20, 2021, 1:43PM
Globe Newswire - Nov 10, 2022, 8:00AM
Globe Newswire - Sep 20, 2022, 8:00AM
Globe Newswire - Sep 19, 2022, 7:00AM
Globe Newswire - Sep 6, 2022, 7:00AM
Globe Newswire - Jun 2, 2022, 8:03AM
Globe Newswire - May 16, 2022, 8:00AM
Globe Newswire - May 5, 2022, 8:00AM
Globe Newswire - Apr 29, 2022, 9:09AM
InvestorsObserver - Oct 13, 2022, 3:37PM
InvestorsObserver - Sep 14, 2022, 6:49AM
StockNews - May 13, 2022, 10:39AM
StockNews - Apr 27, 2022, 6:23AM
InvestorsObserver - Feb 25, 2022, 9:00AM
Seeking Alpha - Dec 7, 2021, 7:29AM
Sector: Health Care.Industry: Biotechnology
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-0.080-0.090 -0.0100
REV66.730M67.689M959.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy MiMedx Group (MDXG) stock?

A

You can purchase shares of MiMedx Group (NASDAQ: MDXG) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are MiMedx Group's (MDXG) competitors?

Q

What is the target price for MiMedx Group (MDXG) stock?

A

The latest price target for MiMedx Group (NASDAQ: MDXG) was reported by Mizuho on Thursday, October 13, 2022. The analyst firm set a price target for 7.00 expecting MDXG to rise to within 12 months (a possible 120.82% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for MiMedx Group (MDXG)?

A

The stock price for MiMedx Group (NASDAQ: MDXG) is $3.17 last updated Today at November 28, 2022, 5:30 PM UTC.

Q

Does MiMedx Group (MDXG) pay a dividend?

A

There are no upcoming dividends for MiMedx Group.

Q

When is MiMedx Group (NASDAQ:MDXG) reporting earnings?

A

MiMedx Group’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is MiMedx Group (MDXG) going to split?

A

There is no upcoming split for MiMedx Group.

Q

What sector and industry does MiMedx Group (MDXG) operate in?

A

MiMedx Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.